Sellas Life Sciences Group Inc (SLS)
Operating Income Growth
-29.56%
TTM · Period ending:
SLS Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-29.56%period ending
Latest reported-29.56%period ending
SLS TTM Operating Income YoY % (-33.18% → -29.56%)
Year-over-year change
High-resolution chart · PNG
SLS operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -29.5626% | |
| -12.6454% | |
| 10.2783% | |
| 17.8048% | |
| 21.8969% | |
| 22.9128% | |
| 16.7842% | |
| 16.2655% | |
| 5.739% | |
| 0.7206% | |
| -18.5258% | |
| -37.6983% | |
| -30.6824% | |
| -51.5363% | |
| -63.0601% | |
| -59.3754% | |
| -84.0771% | |
| -58.834% | |
| -15.381% | |
| 45.7339% | |
| 52.8535% | |
| 53.0674% | |
| 47.9128% | |
| -74.2986% | |
| -57.2298% | |
| -39.3307% | |
| -33.0029% | |
| 29.6403% | |
| 17.3512% | |
| 4.2609% | |
| -6.5458% | |
| -24.2719% | |
| -15.9003% | |
| 4.0412% | |
| 22.6317% | |
| 29.3632% | |
| 37.9225% | |
| 30.5754% | |
| 22.4953% | |
| 27.0084% | |
| 24.8365% | |
| 29.1071% | |
| 26.4304% | |
| 21.2651% | |
| 1.1691% | |
| -31.2324% | |
| -54.1135% | |
| -96.2465% | |
| -82.3717% | |
| -67% | |
| -59.6302% | |
| -26.303% | |
| -32.9145% | |
| -46.865% | |
| -26.1995% | |
| -45.948% | |
| -29.1956% | |
| 8.662% | |
| -1.0406% | |
| 19.394% | |
| 19.0043% | |
| 7.2177% | |
| 10.2128% | |
| -5.5568% | |
| -10.3943% | |
| -17.4255% | |
| -27.2315% | |
| -30.1018% | |
| -31.9045% | |
| -20.9564% | |
| -21.9253% | |
| -33.1827% |